Scrip
Face-to-face: The FDA, Amgen, and its blockbuster biologic, denosumab
15 June 2009
Christopher Spillane
Please Login to read the full article.
15 June 2009
Christopher Spillane
In escaping the sweltering heat of America's south, Scrip's US reporter Christopher Spillane meets Amgen's chief medical officer, Dr Sean Harper , who coolly explains how the firm plans to negotiate the US FDA's unpredictable regulatory waters for its biologic blockbuster denosumab.
In...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Jimenez to take over as CEO as Novartis results beat expectations
- Expect a long wait for FDA social media guidelines, experts say, as agency braves a new world
- Commentary: Mapping out Novartis's "pathways" approach to R&D
- No clear path forward for secondary-progressive MS, says BioMS
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
